[HTML] nih.gov

COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)

Y Song, M Zhang, L Yin, K Wang, Y Zhou… - International journal of …, 2020 - Elsevier
Currently, there is no approved therapy for coronavirus disease 2019 (COVID-19). The
World Health Organization (WHO) therefore endorses supportive care only. However …
被引用次数：258 相关文章 所有 11 个版本
[HTML] nih.gov

Recent progress of antiviral therapy for coronavirus disease 2019

M Zhao, J Zhang, H Li, Z Luo, J Ye, Y Xu… - European journal of …, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic has become a global public
health crisis, for which antiviral treatments are considered mainstream therapeutic …
被引用次数：42 相关文章 所有 6 个版本
[PDF] springer.com

An update on current therapeutic drugs treating COVID-19

R Wu, L Wang, HCD Kuo, A Shannar, R Peter… - Current pharmacology …, 2020 - Springer
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
被引用次数：656 相关文章 所有 11 个版本
[HTML] nih.gov

Current pharmacological treatments for SARS-COV-2: A narrative review

G Nittari, G Pallotta, F Amenta, SK Tayebati - European Journal of …, 2020 - Elsevier
The novel coronavirus, later identified as SARS-CoV-2, originating from Wuhan in China in
November 2019, quickly spread around the world becoming a pandemic. Despite the …
被引用次数：47 相关文章 所有 8 个版本
[HTML] nih.gov

[HTML][HTML] Medical management of COVID-19: evidence and experience

S Bose, S Adapa, NR Aeddula, S Roy… - Journal of clinical …, 2020 - ncbi.nlm.nih.gov
Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale …
被引用次数：54 相关文章 所有 11 个版本
[HTML] nih.gov

Old and re-purposed drugs for the treatment of COVID-19

SS Jean, PR Hsueh - Expert review of anti-infective therapy, 2020 - Taylor & Francis
Introduction: The coronavirus disease 2019 (COVID-19) caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed since December 2019. It …
被引用次数：83 相关文章 所有 7 个版本
[PDF] mdpi.com

Clinical management of COVID-19: a review of pharmacological treatment options

AM Heustess, MA Allard, DK Thompson, PS Fasinu - Pharmaceuticals, 2021 - mdpi.com
Since the outbreak and subsequent declaration of COVID-19 as a global pandemic in March
2020, concerted efforts have been applied by the scientific community to curtail the spread of …
被引用次数：37 相关文章 所有 10 个版本
[HTML] sciencedirect.com

[HTML][HTML] Treatment options for COVID-19: The reality and challenges

SS Jean, PI Lee, PR Hsueh - Journal of microbiology, immunology and …, 2020 - Elsevier
An outbreak related to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
was first reported in Wuhan, China in December 2019. An extremely high potential for …
被引用次数：639 相关文章 所有 12 个版本
[PDF] springer.com

Emerging treatment strategies for COVID-19 infection

M Gavriatopoulou, I Ntanasis-Stathopoulos… - Clinical and …, 2021 - Springer
The new type of coronavirus (COVID-19), SARS-CoV-2 originated from Wuhan, China and
has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused …
被引用次数：364 相关文章 所有 10 个版本
[HTML] nih.gov

COVID-19: A review of the proposed pharmacological treatments

S Lam, A Lombardi, A Ouanounou - European journal of pharmacology, 2020 - Elsevier
The emerging pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
被引用次数：160 相关文章 所有 6 个版本